Endologix Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Endologix (ELGX) Poster Smaller Q3 Loss
November 6, 2019 5:27 PM ESTEndologix (NASDAQ: ELGX) reported Q3 EPS of ($0.40), $0.32 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $35.8 million versus the consensus estimate of $35.38 million.
Our persistent focus on execution has resulted in improved performance across the business... More
